Association between anticoagulation strategy and quality of life in chronic hemodialysis patients

Atrial fibrillation in patients with end‐stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation - Research and Practice in Thrombosis and Haemostasis

Health-Related Quality of Life in People Across the Spectrum of CKD - ScienceDirect

Biomedicines, Free Full-Text

Atrial fibrillation: comorbidities, lifestyle, and patient factors - The Lancet Regional Health – Europe

Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week - ScienceDirect

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19

Frontiers Direct Oral Anticoagulants vs. Warfarin in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis

Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study

Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19